GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Other Stockholders Equity

BioVaxys Technology (BioVaxys Technology) Other Stockholders Equity : $0.14 Mil (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Other Stockholders Equity?

BioVaxys Technology's Other Stockholders Equity for the quarter that ended in Jul. 2023 was $0.14 Mil.

BioVaxys Technology's quarterly Other Stockholders Equity increased from Jan. 2023 ($-0.00 Mil) to Apr. 2023 ($0.14 Mil) and increased from Apr. 2023 ($0.14 Mil) to Jul. 2023 ($0.14 Mil).

BioVaxys Technology's annual Other Stockholders Equity declined from Oct. 2020 ($0.00 Mil) to Oct. 2021 ($0.00 Mil) and declined from Oct. 2021 ($0.00 Mil) to Oct. 2022 ($-0.00 Mil).


BioVaxys Technology Other Stockholders Equity Historical Data

The historical data trend for BioVaxys Technology's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Other Stockholders Equity Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Other Stockholders Equity
- - - - -

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.14 0.14

BioVaxys Technology Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


BioVaxys Technology Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

BioVaxys Technology (BioVaxys Technology) Headlines